Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 6
2021 7
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆.
Lacouture ME, Sibaud V, Gerber PA, van den Hurk C, Fernández-Peñas P, Santini D, Jahn F, Jordan K; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Lacouture ME, et al. Ann Oncol. 2021 Feb;32(2):157-170. doi: 10.1016/j.annonc.2020.11.005. Epub 2020 Nov 25. Ann Oncol. 2021. PMID: 33248228 Free article. No abstract available.
Acne Syndromes and Mosaicism.
Baroud S, Wu J, Zouboulis CC. Baroud S, et al. Biomedicines. 2021 Nov 21;9(11):1735. doi: 10.3390/biomedicines9111735. Biomedicines. 2021. PMID: 34829964 Free PMC article. Review.
Several systemic disorders, such as congenital adrenal hyperplasia, polycystic ovarian syndrome, and seborrhoea-acne-hirsutism-androgenetic alopecia syndrome have classically been associated with acne. Autoinflammatory syndromes, including PAPA, PASH, PAPASH, PsAPASH, PsaP …
Several systemic disorders, such as congenital adrenal hyperplasia, polycystic ovarian syndrome, and seborrhoea-acne-hirsutism-androgenetic …
Learning From Success and Failure: Biologics for Non-approved Skin Diseases.
Speeckaert R, Lambert J, van Geel N. Speeckaert R, et al. Front Immunol. 2019 Aug 8;10:1918. doi: 10.3389/fimmu.2019.01918. eCollection 2019. Front Immunol. 2019. PMID: 31440261 Free PMC article. Review.
Failure of IL-17 blockade in skin diseases resulting from immune-mediated cell destruction (e.g., alopecia areata and vitiligo) illustrates its limited involvement in Th1-dependent skin immunology. Overall, disappointing results of TNF-alpha blockers in alopecia are …
Failure of IL-17 blockade in skin diseases resulting from immune-mediated cell destruction (e.g., alopecia areata and vitiligo) illus …
EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.
Nowaczyk J, Fret K, Kaminska-Winciorek G, Rudnicka L, Czuwara J. Nowaczyk J, et al. Anticancer Drugs. 2023 Sep 1;34(8):942-948. doi: 10.1097/CAD.0000000000001494. Epub 2023 Jan 24. Anticancer Drugs. 2023. PMID: 36708507 Free PMC article. Review.
EGFR inhibitors used in cancer treatment may cause a broad spectrum of dose-dependent cutaneous adverse events, including acneiform papulopustular rash, nail and hair disturbances, xerosis, and mucositis. ...One of the rare, yet distressing adverse events may be folliculit …
EGFR inhibitors used in cancer treatment may cause a broad spectrum of dose-dependent cutaneous adverse events, including acneiform p …
Immunosuppressant-induced cutaneous drug reactions in solid organ transplant recipients.
Miotto IZ, Souza BCE, Tyring SK, de Oliveira WRP. Miotto IZ, et al. Transpl Immunol. 2021 Feb;64:101355. doi: 10.1016/j.trim.2020.101355. Epub 2020 Nov 29. Transpl Immunol. 2021. PMID: 33264680
Among 532 SOTRs followed at our dermatology clinic, 60 (11.3%) developed some cutaneous adverse reactions to the immunosuppressants, with a median age at transplantation of 50.5 years and a median life span posttransplantation of seven years. Acneiform eruption was the mos …
Among 532 SOTRs followed at our dermatology clinic, 60 (11.3%) developed some cutaneous adverse reactions to the immunosuppressants, with a …
Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.
Chanprapaph K, Pomsoong C, Kositkuljorn C, Suchonwanit P. Chanprapaph K, et al. Drug Des Devel Ther. 2022 Jan 7;16:107-116. doi: 10.2147/DDDT.S342179. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35027820 Free PMC article.
INTRODUCTION: Intramuscular corticosteroids (IMC) have gained popularity for the treatment of severe alopecia areata (AA) in recent years; however, evidence on their efficacy and safety is still limited. ...Complete hair regrowth was achieved in 48.5% of the subjects (n = …
INTRODUCTION: Intramuscular corticosteroids (IMC) have gained popularity for the treatment of severe alopecia areata (AA) in recent y …
Experience with oral tofacitinib in severe alopecia areata with different clinical responses.
Dincer Rota D, Emeksiz MAC, Erdogan FG, Yildirim D. Dincer Rota D, et al. J Cosmet Dermatol. 2021 Sep;20(9):3026-3033. doi: 10.1111/jocd.13966. Epub 2021 Feb 7. J Cosmet Dermatol. 2021. PMID: 33533091
BACKGROUND: Alopecia areata (AA) and generalized form, universalis (AU) are common causes of noncicatricial alopecia, targeting anagen hair follicles. ...The demographic features and the treatment responses were evaluated with Severity of Alopecia Tool score …
BACKGROUND: Alopecia areata (AA) and generalized form, universalis (AU) are common causes of noncicatricial alopecia, targetin …
Folliculotropic Mycosis Fungoides In A Child: A Rare Case.
Zahoor F, Junaid S, Afzal G. Zahoor F, et al. J Pak Med Assoc. 2023 Nov;73(11):2260-2262. doi: 10.47391/JPMA.8348. J Pak Med Assoc. 2023. PMID: 38013542 Free article.
The clinical presentation of FMF may include prurigo-like lesions, acneiform lesions, cysts, nodules, areas of scarring alopecia, and hypopigmented plaques or papules with follicular prominences. ...
The clinical presentation of FMF may include prurigo-like lesions, acneiform lesions, cysts, nodules, areas of scarring alopecia …
Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology.
Bailey CAR, Laurain DA, Sheinbein DM, Jones HA, Compton LA, Rosman IS. Bailey CAR, et al. J Cutan Pathol. 2021 Mar;48(3):439-450. doi: 10.1111/cup.13932. Epub 2020 Dec 18. J Cutan Pathol. 2021. PMID: 33617128 Review.
Within the literature, there is overlap in the histopathological features described in eosinophilic folliculitis associated with chronic lymphocytic leukemia (CLL), eosinophilic dermatosis of hematologic malignancy, and acneiform follicular mucinosis. These disorders are d …
Within the literature, there is overlap in the histopathological features described in eosinophilic folliculitis associated with chronic lym …
15 results